Mirum Pharmaceuticals (MIRM) Profit After Tax (2019 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly Profit After Tax came in at -$790.2 million in Q1 2026, down 5283.63% year-on-year from $15.2 million in Q1 2025, and down 13689.79% quarter-over-quarter from -$5.7 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Profit After Tax (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Profit After Tax history runs 8 years deep, the most recent figure standing at -$790.2 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 5283.63% year-over-year to -$790.2 million in Q1 2026; TTM through Mar 2026 was -$798.8 million, a 932.9% decrease from a year earlier, with the FY2025 full-year figure at -$23.4 million, up 73.43% from the prior year.
- Profit After Tax fell to -$790.2 million in Q1 2026 per MIRM's latest filing, from -$5.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $2.9 million in Q3 2025 and bottomed at -$790.2 million in Q1 2026.
- The 5-year median for Profit After Tax is -$25.3 million (2024), against an average of -$70.6 million.
- Across the five-year window, Profit After Tax soared 120.41% in 2025 and sank 5283.63% in 2026, its largest moves.
- Year by year, Profit After Tax stood at -$36.4 million in 2022, then increased by 2.12% to -$35.7 million in 2023, then surged by 33.28% to -$23.8 million in 2024, then soared by 75.91% to -$5.7 million in 2025, then slumped by 13689.79% to -$790.2 million in 2026.
- Per Business Quant, the three latest MIRM Profit After Tax figures stand at -$790.2 million (Q1 2026), -$5.7 million (Q4 2025), and $2.9 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Mirum Pharmaceuticals | 6.66 Bn | 6.27 Bn | 131.08 Mn | -790.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -790.16 Mn |
| Dec 31, 2025 | -5.73 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Jun 30, 2025 | -5.86 Mn |
| Mar 31, 2025 | -14.68 Mn |
| Dec 31, 2024 | -23.79 Mn |
| Sep 30, 2024 | -14.24 Mn |
| Jun 30, 2024 | -24.64 Mn |
| Mar 31, 2024 | -25.28 Mn |
| Dec 31, 2023 | -35.66 Mn |
| Sep 30, 2023 | -23.59 Mn |
| Jun 30, 2023 | -74.04 Mn |
| Mar 31, 2023 | -30.13 Mn |
| Dec 31, 2022 | -36.43 Mn |
| Sep 30, 2022 | -35.71 Mn |
| Jun 30, 2022 | -26.92 Mn |
| Mar 31, 2022 | -36.61 Mn |
| Dec 31, 2021 | 57.55 Mn |
| Sep 30, 2021 | -47.11 Mn |
| Jun 30, 2021 | -43.89 Mn |